Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID Mutants: Vaccine Changes Likely To Need Immunogenicity Studies, Not Big Efficacy Trials

New Coronavirus variant outbreak and covid-19 virus cell mutation — New coronavirus variants are complicating the vaccination effort • Source: Shutterstock

Related Content

US Officials Hope To Identify Correlates of Protection For COVID-19 Vaccines Shortly

Jan 12 2021

Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants

Jan 26 2021

BioNTech: We Could Produce New COVID Variant Vaccine In Six Weeks, If Needed

Dec 22 2020

Related Companies

Moderna, Inc.

Pfizer Inc.

BioNTech SE

Additional Topics

United States Coronavirus COVID-19 Vaccines Regulation Manufacturing Clinical Trials Research & Development Infectious Diseases BioPharmaceutical

More from Vaccines

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window